Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 23 ... one of the most important infectious diseases of humans and animals. Mycobacterium bovis BCG, the only currently available TB vaccine, demonstrates variable levels of efficacy; ...
2009 OCT 12 ... braziliensis M2903 monovalent vaccines associated with Bacillus Calmette-Guerin (BCG) was established, one round of which also included an M2903 vaccine associated with ...
2009 OCT 12 ... neonatal dosing would fit with the World Health Organization schedule that includes a BCG vaccine at birth and additional immunization visits at six, 10, and 14 weeks. The ...
2009 OCT 12 ... was investigated in the spleen and lung digest cells of bacillus Calmette-Guerin (BCG)-vaccinated and non-vaccinated guinea pigs following low-dose, pulmonary exposure to ... our results suggest that type I cytokine mRNA expression is not associated with vaccine-induced protection in the low-dose guinea pig model of tuberculosis." ...
2009 SEP 7 ... of healthy controls from an area where TB is endemic (ECs). M. tuberculosis-, M. bovis BCG-, ESAT6-, and culture filtrate protein 10 (CFP10)-induced responses were determined in ... Hasan and colleagues published the results of their research in Clinical and Vaccine Immunology (Differential Live Mycobacterium tuberculosis-, M-bovis BCG-, Recombinant ...
2009 NOV 23 ... peptide induced significantly stronger specific antibodies than the classical TB vaccine-BCG (bacillus Calmette-Guerin). Compared with BCG, the stimulation index in the ...
2009 NOV 1 ... "This case highlights the importance of the correct administration and dosing of BCG vaccine and suggests a management option that may prevent the severe local and systemic ...
2009 AUG 10 ... Shenzhen, China, where the prevalence of tuberculosis is severe and Mycobacterium bovis BCG vaccination is mandatory at birth. A total of 305 patients with active tuberculosis, 18 ... TB infections." Chen and colleagues published their study in Clinical and Vaccine Immunology (Diagnosis of Active Tuberculosis in China Using an In-House Gamma Interferon ...
2009 AUG 3 ... is seriously compromised because of extensive use of the bacille Calmette-Guerin (BCG) vaccination. The interferon-gamma release assay (IGRA), a new diagnostic using ... Treatment, Vaccination, Virology. This article was prepared by AIDS Vaccine Week editors from staff and other reports. Copyright 2009, AIDS Vaccine Week via ...
2009 NOV 23 ... to recent research from Tokyo, Japan, "The ability of a recombinant Mycobacterium bovis BCG strain that secretes major membrane protein II (MMP-II) of Mycobacterium leprae (BCG-SM) ... "These results indicate that a BCG strain that secretes MMP-II could be a better vaccine candidate for leprosy." Maeda and colleagues published their study in ...
2009 SEP 7 ... immunization with five different types of TB vaccine preparations (Mycobacterium bovis BCG, an attenuated M. tuberculosis mutant strain, a DNA vaccine, a modified vaccinia virus ...
2009 OCT 5 ... to development of effective vaccine strategies. WTD were vaccinated with either M. bovis BCG strain Pasteur or BCG strain Danish." "Both vaccinees and unvaccinated ...
2009 NOV 28 ... Fifty-eight percent of patients were completely vaccinated for HBV, 85% for OPV, 97% for BCG, 63% for DTP, and 58% of the patients were completely vaccinated for MMR. We concluded ... childhood immunizations at the time of transplantation and who are therefore at risk for vaccine-preventable infections," scientists writing in the journal Pediatric Transplantation ...
2009 NOV 23 ... about the safety and efficacy of Mycobacterium bovis bacillus Calmette-Guerin (BCG) emphasize the need for alternative tuberculosis (TB) vaccines. DNA vaccines are ... and cellular immunology have paved the way toward the rational design of an efficacious vaccine. We exploited self-cleaving peptide 2A from the foot-and-mouth disease virus, because of ...
2009 AUG 3 ... Mycobacterium tuberculosis (M.tb)challenge over that by AdAg85a or by conventional BCG immunization with similarly induced levels of protection in the spleen," wrote J.Y. Mu ... the functional differences and support the advantage of multivalent virus-vectored vaccine over its monovalent counterpart." "We previously successfully developed a ...
2009 SEP 28 ... "Significant variability in efficacy of live Mycobacterium bovis BCG as a tuberculosis vaccine is observed globally. Effects of pre-vaccination sensitisation ...
2009 AUG 10 ... a strong, vaccine-specific proliferative potential. Long-term memory induced by the BCG vaccine contained fewer multifunctional T cells and was biased toward effector cells mainly of ...
2009 OCT 12 ... A report, 'Lactoferrin modulation of BCG-infected dendritic cell functions,' is newly published data in International ... to enhance efficacy of the existing Mycobacterium bovis Bacillus Calmette Guerin (BCG) vaccine to protect against murine model of tuberculosis. Although identified as having effects ...
